Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4181 | 1756 | 27.0 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
492 | 14766 | CONTRACEPTION//EMERGENCY CONTRACEPTION//MEDICAL ABORTION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CONTRACEPTION | Journal | 113 | 15% | 40% | 694 |
2 | ETONOGESTREL | Author keyword | 80 | 71% | 4% | 65 |
3 | NORPLANT | Author keyword | 74 | 65% | 4% | 71 |
4 | DEPOT MEDROXYPROGESTERONE ACETATE | Author keyword | 74 | 63% | 4% | 75 |
5 | IMPLANON | Author keyword | 71 | 84% | 2% | 38 |
6 | NORPLANT IMPLANTS | Author keyword | 57 | 95% | 1% | 19 |
7 | IMPLANON R | Author keyword | 51 | 83% | 2% | 29 |
8 | CYCLOFEM | Author keyword | 50 | 88% | 1% | 23 |
9 | MESIGYNA | Author keyword | 38 | 93% | 1% | 14 |
10 | CONTRACEPTIVE IMPLANTS | Author keyword | 36 | 79% | 1% | 23 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ETONOGESTREL | 80 | 71% | 4% | 65 | Search ETONOGESTREL | Search ETONOGESTREL |
2 | NORPLANT | 74 | 65% | 4% | 71 | Search NORPLANT | Search NORPLANT |
3 | DEPOT MEDROXYPROGESTERONE ACETATE | 74 | 63% | 4% | 75 | Search DEPOT+MEDROXYPROGESTERONE+ACETATE | Search DEPOT+MEDROXYPROGESTERONE+ACETATE |
4 | IMPLANON | 71 | 84% | 2% | 38 | Search IMPLANON | Search IMPLANON |
5 | NORPLANT IMPLANTS | 57 | 95% | 1% | 19 | Search NORPLANT+IMPLANTS | Search NORPLANT+IMPLANTS |
6 | IMPLANON R | 51 | 83% | 2% | 29 | Search IMPLANON+R | Search IMPLANON+R |
7 | CYCLOFEM | 50 | 88% | 1% | 23 | Search CYCLOFEM | Search CYCLOFEM |
8 | MESIGYNA | 38 | 93% | 1% | 14 | Search MESIGYNA | Search MESIGYNA |
9 | CONTRACEPTIVE IMPLANTS | 36 | 79% | 1% | 23 | Search CONTRACEPTIVE+IMPLANTS | Search CONTRACEPTIVE+IMPLANTS |
10 | CONTRACEPTIVE IMPLANT | 28 | 60% | 2% | 31 | Search CONTRACEPTIVE+IMPLANT | Search CONTRACEPTIVE+IMPLANT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROVERA | 117 | 86% | 3% | 60 |
2 | SUBDERMAL IMPLANTS | 107 | 93% | 2% | 40 |
3 | NORPLANT IMPLANTS | 82 | 88% | 2% | 38 |
4 | DEPOT MEDROXYPROGESTERONE ACETATE | 80 | 38% | 10% | 168 |
5 | IMPLANONR | 53 | 85% | 2% | 28 |
6 | NORPLANTR IMPLANTS | 51 | 79% | 2% | 33 |
7 | NORPLANT | 44 | 52% | 3% | 61 |
8 | ONCE A MONTH | 38 | 89% | 1% | 17 |
9 | ETONOGESTREL | 33 | 67% | 2% | 29 |
10 | ORTHO EVRATM EVRATM | 32 | 80% | 1% | 20 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONTRACEPTION | 113 | 15% | 40% | 694 |
2 | ADVANCES IN CONTRACEPTION | 3 | 12% | 1% | 22 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Current status of contraceptive vaginal rings | 2013 | 10 | 82 | 70% |
The contraceptive efficacy of Implanon (R): A review of clinical trials and marketing experience | 2008 | 32 | 8 | 100% |
Progestogen-only contraception and bone mineral density: a systematic review | 2006 | 57 | 45 | 84% |
The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users | 2011 | 14 | 38 | 71% |
Bone density recovery after depot medroxyprogesterone acetate injectable contraception use | 2008 | 46 | 70 | 63% |
The effects of Implanon (R) on menstrual bleeding patterns | 2008 | 39 | 28 | 68% |
Hormonal contraception and bone metabolism: a systematic review | 2012 | 17 | 165 | 47% |
Steroidal contraceptives: effect on bone fractures in women | 2011 | 10 | 45 | 76% |
Contraceptive vaginal rings: a review | 2010 | 15 | 77 | 78% |
Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons | 2009 | 12 | 35 | 97% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FAMILY PLANNING CLIN | 5 | 33% | 0.7% | 12 |
2 | AMIRCOLA HOSP | 4 | 75% | 0.2% | 3 |
3 | GRAINGERVILLE CLIN | 3 | 50% | 0.3% | 5 |
4 | HUMAN REPROD UNIT OBSTET GYNAECOL | 2 | 67% | 0.1% | 2 |
5 | KLIN RADEN SALEH | 2 | 67% | 0.1% | 2 |
6 | NEWCASTLE UPON TYNE CONTRACEPT SEXUAL HLTH SERV | 2 | 67% | 0.1% | 2 |
7 | OBSTET GYNECOL WOMEN HLTH | 2 | 67% | 0.1% | 2 |
8 | PESQUISA DOENCAS MATERNO INFANTIS CAMPINAS | 2 | 67% | 0.1% | 2 |
9 | SYDNEY REPROD HLTH | 2 | 21% | 0.5% | 9 |
10 | CONSULTORIO PLANIFICAC FAMILIAR | 2 | 50% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000201793 | DESOGESTREL//ORAL CONTRACEPTIVES//DROSPIRENONE |
2 | 0.0000185039 | UNINTENDED PREGNANCY//CONTRACEPTION//LONG ACTING REVERSIBLE CONTRACEPTION |
3 | 0.0000122782 | LACTATIONAL AMENORRHEA METHOD//LACTATIONAL AMENORRHEA//LACTATIONAL AMENORRHOEA |
4 | 0.0000104603 | INTRAUTERINE DEVICE//CONTRACEPTIVE DELIVERY SYSTEMS//INTRAUTERINE CONTRACEPTIVE DEVICE |
5 | 0.0000085764 | ETHINYLESTRADIOL//GESTODENE//CAS 57 63 6 |
6 | 0.0000080521 | ENDOMETRIAL BLEEDING//BREAKTHROUGH BLEEDING//SYDNEY REPROD HLTH |
7 | 0.0000065077 | P450 ENZYME//ENZYMELESS BIOSENSORS//IRON TETRAPYRIDINOPORPHYRAZINE |
8 | 0.0000061542 | NONOXYNOL//OCTOXYNOL 9//SEXUALLY TRANSMITTED DISEASE CONTROL |
9 | 0.0000058536 | EMERGENCY CONTRACEPTION//POSTCOITAL CONTRACEPTION//MORNING AFTER PILL |
10 | 0.0000055395 | C TRACHOMATIS INFECTION//CDC INFORMAT SYST SUPPORT SERV//DRUGS CARDIOVASCULAR |